About lifespin®

lifespin is a pioneering, cross-disciplinary technology company merging NMR, metabolomics and AI to enable a new paradigm of healthcare that is personalized and equitable.

At lifespin, we envision a world where healthcare is proactive, personalized, and accessible to all. By harnessing the power of metabolomic profiling, we aim to shift the focus from reactive treatment to early detection, prevention and optimized treatment, enabling people to live healthier, longer lives – regardless of their location or financial status.

Our mission is to democratize healthcare by providing affordable, data-driven, and scalable solutions for comprehensive health assessments. Through advanced biomarker analysis, we deliver personalized health insights that empower physicians and individuals to make informed decisions. By integrating cutting-edge technology, artificial intelligence, and a seamless user experience, we bridge the gap between scientific innovation and everyday healthcare – transforming lives globally.

Team

At lifespin, we are a cross-disciplinary team of biologists, biochemists, chemists, physicists and mathematicians. The combined power of deep technical expertise, understanding for the healthcare ecosystem and regulatory expertise, we enable the precision medicine of tomorrow.

Leadership Team

Excellence in science, technology and business

Dr. Sonja Wiedemann

CEO & CTO

Dr. Ali Tinazli

CEO & CCO

Dr. Roland Geyer

COO

Advisory board

Expert guidance for strategic decisions

Prof. Dr. James Rothman

Sterling-Professor of Cell Biology , Yale University, Nobel Laureate for Physiology / Medicine

Nobel Laureate Physiology/ Medicine 2013

Dr. Trevor Hawkins

Seasoned Senior Executive & Industry Veteran in Diagnostics

Previously Director of the Human Genome Project for the US.DOE, and held senior executive roles at Siemens Healthcare, Philips, GE Healthcare and Amersham.

Prof. Dr. Felix Wieland

Senior Professor for Biochemistry Heidelberg University

Prof. Wieland is an elected Member of the Academia Europea and the National Academy of Sciences, Leopoldina, as well as an Honorary member of the Charité.

Prof. Dr. Andreas Krumpel

Bioengineering/ Phsysics and Mathematics Weihenstephan University of Applied Sciences

Dr. Philip Stevens

CTO and Co-Founder Noscendo

Prof. Dr. med. Dr. h.c. Uwe Heemann

Professor for Nephrology TU Munich, Leader nephrology TUM Clinic Rechts der Isar

Our Journey

Scientific Collaborations & Research Projects

DeepHealth Grant Awarded

Lifespin and Hochschule Weihenstephan-Triesdorf receive funding from the Bayerische Forschungsstiftung for the DeepHealth research initiative focusing on AI development

September 2025

Strategic Partnerships & Go-to-Market

First three Cloud-Connected NMR Systems Deployed

Rollout of cloud-integration of NMR systems in Germany, Turkey, and Saudi Arabia.

April 2025

Strategic Partnerships & Go-to-Market

Go-to-Market Partnership in Malaysia

Partnership with Premier Integrated Labs to introduce AI-powered metabolomic diagnostics in the Malaysian market.

March 2025

Technological & Product Development

Release of MetaboPRO

Launch of the first generation of lifespin’s General Health Assessment: MetaboPRO.

March 2025

Technological & Product Development

Integration of Home-Collection Device

Expansion of test accessibility through home-based sample collection technology.

February 2025

Data Milestones

250,000 Metabolic Profiles in Database

Lifespin’s database surpasses 250,000 human metabolic profiles.

February 2025

Technological & Product Development

Release of lipoPRO

Launch of lifespin’s advanced lipoprotein profiling solution.

October 2024

Technological & Product Development

Launch of Lifespin CLOUD – the platform for global access allowing decentralized sample measurement

Launch of the cloud-based platform for NMR data processing and remote diagnostics enabling global access to lifespin solutions.

October 2024

Strategic Partnerships & Go-to-Market

Commercial Collaboration with Acıbadem Healthcare Group to build a precision medicine platform

Strategic collaboration with Acıbadem University and Acıbadem Healthcare Group to build an AI-enabled, NMR-based precision medicine platform for Eurasia and beyond.

May 2024

Technological & Product Development

Release of First Commercial In-House IVD (Amino Acid Profiler)

Release of the Lifespin Amino Acid Profiler (LAAP), a laboratory-developed test quantifying 26 amino acids from 0.5 ml of blood.

May 2023

Scientific Collaborations & Research Projects

Partnership with Leipzig Research Center (LIFE)

Collaboration established to gain deep clinical insights into obesity and diabetes.

April 2023

Certifications & Regulatory Compliance

ISO 13485 Certification

Achievement of ISO 13485 certification for medical devices.

February 2023

Scientific Collaborations & Research Projects

Scientific Collaboration with Medical University of Graz

Integration of ~25,000 longitudinal oncological blood samples from Biobank Graz into lifespin’s database.

July 2022

Data Milestones

100,000 Metabolic Profiles in Database

Lifespin reaches 100,000 human metabolic profiles in its proprietary database.

July 2021

Scientific Collaborations & Research Projects

Cooperation with BRK Blood Donor Service

Strategic collaboration to analyze over 100,000 blood donor samples.

April 2019

Certifications & Regulatory Compliance

ISO 9001 Certification

Achievement of ISO 9001 certification for quality management systems.

January 2019

Operational & Capacity Expansion

Start of Operations

Installation of the first NMR system; commencement of life science service operations.

October 2018

Company & Leadership Milestones

Founding of Lifespin GmbH

Lifespin GmbH was founded at BioPark in Regensburg, Germany.

April 2017
Scroll to Top
video-thumb

Dr. Roland Geyer

COO
10+ years experience in NMR-based metabolomics and diagnostic.

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.

Dr. Ali Tinazli

CEO, lifespin GmbH

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).